Page 219 - EJMO-9-2
P. 219

Eurasian Journal of
            Medicine and Oncology                                             Tetramethyl thyroxine boosts bladder cancer



               doi: 10.1111/acel.13260                         35.  Weis SM, Cheresh DA.  αV integrins in angiogenesis and
                                                                  cancer. Cold Spring Harb Perspect Med. 2011;1(1):a006478.
            24.  Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ. Thyroid
               hormone causes mitogen-activated protein kinase-     doi: 10.1101/cshperspect.a006478
               dependent phosphorylation of the nuclear estrogen receptor.
               Endocrinology. 2004;145(7):3265-3272.           36.  Bao W, Strömblad S. Integrin alphav-mediated inactivation
                                                                  of p53 controls a MEK1-dependent melanoma cell
               doi: 10.1210/en.2004-0308                          survival pathway in three-dimensional collagen. J Cell Biol.
            25.  Davis PJ, Hercbergs A, Luidens MK, Lin HY. Recurrence   2004;167(4):745-756.
               of differentiated thyroid carcinoma during full TSH      doi: 10.1083/jcb.200404018
               suppression: Is the tumor now thyroid hormone dependent?
               Horm Cancer. 2014;6(1):7-12.                    37.  Bu MT, Chandrasekhar P, Ding L, Hugo W. The roles  of
                                                                  TGF-β and VEGF pathways in the suppression of antitumor
               doi: 10.1007/s12672-014-0204-z                     immunity in melanoma and other solid tumors. Pharmacol
            26.  Meng R, Tang HY, Westfall J,  et al. Crosstalk between   Ther. 2022;240:108211.
               integrin αvβ3 and estrogen receptor-α is involved in thyroid      doi: 10.1016/j.pharmthera.2022.108211
               hormone-induced proliferation in human lung carcinoma
               cells. PLoS One. 2011;6(11):e27547.             38.  Morgos DT, Stefani C, Miricescu D, et al. Targeting PI3K/
                                                                  AKT/mTOR and MAPK signaling pathways in gastric
               doi: 10.1371/journal.pone.0027547                  cancer. Int J Mol Sci. 2024;25(3):1848.
            27.  Chen JR, Zhao JT, Xie ZZ. Integrin-mediated cancer      doi: 10.3390/ijms25031848
               progression as a specific target in clinical therapy. Biomed
               Pharmacother. 2022;155:113745.                  39.  Xiong C, Ling H, Hao Q, Zhou X. Cuproptosis: p53-regulated
                                                                  metabolic cell death? Cell Death Differ. 2023;30(4):876-884.
               doi: 10.1016/j.biopha.2022.113745
                                                                  doi: 10.1038/s41418-023-01125-0
            28.  Malenica I, Adam J, Corgnac S,  et al. Integrin-α(V)-
               mediated activation of TGF-β regulates anti-tumour CD8 T   40.  Cayres LCF, de Salis LVV, Rodrigues GSP, et al. Detection of
               cell immunity and response to PD-1 blockade. Nat Commun.   alterations in the gut microbiota and intestinal permeability
               2021;12(1):5209.                                   in patients with Hashimoto thyroiditis.  Front Immunol.
                                                                  2021;12:579140.
               doi: 10.1038/s41467-021-25322-y
                                                                  doi: 10.3389/fimmu.2021.579140
            29.  Cheuk IW, Siu MT, Ho JC,  et al. ITGAV targeting as a
               therapeutic approach for treatment of metastatic breast   41.  Sirakov M, Kress E, Nadjar J, Plateroti M. Thyroid
               cancer. Am J Cancer Res. 2020;10(1):211-223.       hormones  and  their  nuclear  receptors:  New  players  in
                                                                  intestinal epithelium stem cell biology?  Cell  Mol Life Sci.
            30.  Wang H, Chen H, Jiang Z, et al. Integrin subunit alpha V
               promotes growth, migration, and invasion of gastric cancer   2014;71(15):2897-2907.
               cells. Pathol Res Pract. 2019;215(9):152531.       doi: 10.1007/s00018-014-1586-3
               doi: 10.1016/j.prp.2019.152531                  42.  Rubingh J, van der Spek A, Fliers E, Boelen A. The role of
            31.  Sato N, Sakai N, Furukawa K, et al. Yin Yang 1 regulates   thyroid hormone in the innate and adaptive immune response
               ITGAV and ITGB1, contributing to improved prognosis of   during infection. Compr Physiol. 2020;10(4):1277-1287.
               colorectal cancer. Oncol Rep. 2022;47(5):87.       doi: 10.1002/cphy.c200003
               doi: 10.3892/or.2022.8298                       43.  Korac-Prlic J, Degoricija M, Vilović K, Vujević S, Terzić J.
            32.  Loeser H, Scholz M, Fuchs H, et al. Integrin alpha V (ITGAV)   BBN-driven urinary bladder cancer mouse model. Methods
               expression in esophageal adenocarcinoma is associated with   Cell Biol. 2021;163:77-92.
               shortened overall-survival. Sci Rep. 2020;10(1):18411.     doi: 10.1016/bs.mcb.2020.10.020
               doi: 10.1038/s41598-020-75085-7                 44.  Matuszczak M, Salagierski M. Diagnostic and prognostic
            33.  Van der Horst G, Bos L, van der Mark M, et al. Targeting of   potential of biomarkers CYFRA 21.1, ERCC1, p53, FGFR3
               alpha-v integrins reduces malignancy of bladder carcinoma.   and TATI in bladder cancers. Int J Mol Sci. 2020;21(9):3360.
               PLoS One. 2014;9(9):e108464.                       doi: 10.3390/ijms21093360
               doi: 10.1371/journal.pone.0108464               45.  Yang CC, Yan YC, Pan GQ, et al. Thyroid hormones inhibit
            34.  Sachs MD, Rauen KA, Ramamurthy M,  et al. Integrin   tumor progression and enhance the antitumor activity of
               alpha(v) and coxsackie adenovirus receptor expression in   lenvatinib in hepatocellular carcinoma via reprogramming
               clinical bladder cancer. Urology. 2002;60(3):531-536.  glucose metabolism. Cell Death Discov. 2025;11(1):92.
               doi: 10.1016/s0090-4295(02)01748-x                 doi: 10.1038/s41420-025-02378-z


            Volume 9 Issue 2 (2025)                        211                         doi: 10.36922/EJMO025080037
   214   215   216   217   218   219   220   221   222   223   224